“…The most commonly used chemotherapy regimen is R-CHOP, which is a combination of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone. [9,10,14] In patients with unfavorable prognostic factors, DA-EPOCH-R (dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) may also be a beneficial treatment option [10,15]. Response to treatment is measured using data collected from the post-treatment history, physical, and imaging (PET/CT) scan results.…”